Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversing the Biological Clock: Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

NCT07707778 is registered in ClinicalTrials.gov with National Taiwan University Clinical Trial Center as lead sponsor.

NCT NCT07707778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07707778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversing the Biological Clock: Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
Lead sponsor
National Taiwan University Clinical Trial Center
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
June 25, 2026
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, dyslipidaemia, human immunodeficiency virus (hiv), metabolic dysfunction associated steatotic liver disease, metabolic syndrome, obesity & overweight